[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-29653":3,"doc-seo-29653":21},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"update_tm":20},29653,7971461740909,"Levi","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d",7,"Healthcare","Factor XA Inhibitors","This document provides critical information about Factor XA inhibitors, specifically focusing on Rivaroxaban (brand name Xarelto), Edoxaban, and Apixaban. It outlines key points for patient education, emphasizing the avoidance of Aspirin and NSAIDs due to increased bleeding risk. Certain supplements like Vitamin E, Garlic, Ginger, Ginkgo, and Omega-3s are also cautioned against. The document highlights the positive aspects, such as a lower bleeding risk compared to warfarin, no need for routine clotting studies, and the absence of dietary restrictions for Vitamin K-rich foods like leafy greens and liver. A memory trick is provided, associating Rivaroxaban with a \"RIVER ROCK band\" where \"blood flows like a river\" to aid recall. Conversely, it warns of the \"bad news\" regarding the risk for neurological impairment, likening the \"Rock think\" band's excessive headbanging to potential brain bleeding, and relating it to HESI-common questions about teaching clients methods to reduce bleeding. The document uses visual aids to represent these points, including a band playing near a red river, graphic representations of prohibited items, and a diagram of a brain with a bleeding indication. It serves as a concise guide for healthcare professionals and patients regarding the safe use and potential risks associated with Factor XA inhibitors.","cbCaigsKu0wMb9d8","https://ap.wps.com/l/cbCaigsKu0wMb9d8","pdf",1140789,1,1778283688,{"code":4,"msg":22,"data":23},"ok",{"site_id":24,"language":25,"slug":26,"title":13,"keywords":27,"description":14,"schema_data":28,"social_meta":63,"head_meta":65,"extra_data":67,"updated_unix":20},105,"en","factor-xa-inhibitors","",{"@graph":29,"@context":62},[30,47],{"@type":31,"itemListElement":32},"BreadcrumbList",[33,37,41,44],{"item":34,"name":35,"@type":36,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":38,"name":39,"@type":36,"position":40},"https://docshare.wps.com/document/","Document",2,{"item":42,"name":12,"@type":36,"position":43},"https://docshare.wps.com/document/healthcare/",3,{"item":45,"name":13,"@type":36,"position":46},"https://docshare.wps.com/document/factor-xa-inhibitors/29653",4,{"url":45,"name":13,"@type":48,"author":49,"headline":13,"publisher":51,"fileFormat":54,"description":14,"dateModified":55,"datePublished":56,"encodingFormat":54,"isAccessibleForFree":57,"interactionStatistic":58},"DigitalDocument",{"name":9,"@type":50},"Person",{"url":34,"name":52,"@type":53},"DocShare","Organization","application/pdf","2026-05-09","2026-05-08",true,{"@type":59,"interactionType":60,"userInteractionCount":19},"InteractionCounter",{"@type":61},"ViewAction","https://schema.org",{"og:url":45,"og:type":64,"og:title":13,"og:site_name":52,"og:description":14},"article",{"robots":66,"canonical":45},"index,follow",{"doc_id":7,"site_id":24}]